Literature DB >> 14364090

Occurrence of myeloid leukemia in patients with metastatic thyroid carcinoma following prolonged massive radioiodine therapy.

S M SEIDLIN, E SIEGEL, S MELAMED, A A YALOW.   

Abstract

Entities:  

Keywords:  IODINE/radioactive; LEUKEMIA, MYELOCYTIC/etiology and pathogenesis; THYROID GLAND/neoplasms

Mesh：

Substances：

Year:  1955        PMID： 14364090

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  5 in total

1.  Hormonal and isotope measure in thyroid carcinoma.

Authors:  C G THOMAS; S G JENKINS
Journal:  Ann Surg       Date:  1963-06       Impact factor: 12.969

2.  Treatment of thyrotoxicosis with 131 I; a review of 500 cases.

Authors:  G W BLOMFIELD; H ECKERT; M FISHER; H MILLER; D S MUNRO; G M WILSON
Journal:  Br Med J       Date:  1959-01-10

3.  Remarks on the pathogenesis and aetiology of acute leukaemia.

Authors:  D BAKALOS
Journal:  Blut       Date:  1958-12

Review 4.  Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Authors:  Frederik A Verburg; Markus Dietlein; Michael Lassmann; Markus Luster; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

5.  Induction of leukemia by 131-I treatment of thyroid carcinoma.

Authors:  H Brincker; H S Hansen; A P Andersen
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.